loader from loading.io

Cloud-Based Vendor-Agnostic EEG Platform Unifies and Standardizes Data with Daniele De Mari Neurogram

Empowered Patient Podcast

Release Date: 06/30/2026

Smart Hearing Aids Hearing Loss and Cognitive Decline with Dr. Rachel Artsma Hear.com TRANSCRIPT show art Smart Hearing Aids Hearing Loss and Cognitive Decline with Dr. Rachel Artsma Hear.com TRANSCRIPT

Empowered Patient Podcast

Dr. Rachel Artsma, lead audiologist at hear.com offers comprehensive hearing care services and she emphasizes how dramatically hearing aids have evolved from earlier generations. Bluetooth connectivity, rechargeable batteries, and real-time environmental adjustments are now being driven by smart chips in the devices, which also allow direct streaming of phone calls, music, and driving directions. Untreated hearing loss can lead to auditory deprivation, in which the brain does not receive clear auditory input, resulting in increased cognitive strain and a decline in cognitive function. Rachel...

info_outline
Smart Hearing Aids Hearing Loss and Cognitive Decline with Dr. Rachel Artsma Hear.com show art Smart Hearing Aids Hearing Loss and Cognitive Decline with Dr. Rachel Artsma Hear.com

Empowered Patient Podcast

Dr. Rachel Artsma, lead audiologist at hear.com offers comprehensive hearing care services and she emphasizes how dramatically hearing aids have evolved from earlier generations. Bluetooth connectivity, rechargeable batteries, and real-time environmental adjustments are now being driven by smart chips in the devices, which also allow direct streaming of phone calls, music, and driving directions. Untreated hearing loss can lead to auditory deprivation, in which the brain does not receive clear auditory input, resulting in increased cognitive strain and a decline in cognitive function. Rachel...

info_outline
Parkinson’s Disease Management Transformed by AI-Powered Longitudinal Tracking with Amy Gordon Franzen Rune Labs TRANSCRIPT show art Parkinson’s Disease Management Transformed by AI-Powered Longitudinal Tracking with Amy Gordon Franzen Rune Labs TRANSCRIPT

Empowered Patient Podcast

Amy Gordon Franzen, CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make more informed treatment decisions. There is also an AI chatbot that allows patients to interrogate their data and receive personalized insights while enabling clinicians and drug developers to...

info_outline
Parkinson’s Disease Management Transformed  by AI-Powered Longitudinal Tracking  with Amy Gordon Franzen Rune Labs show art Parkinson’s Disease Management Transformed by AI-Powered Longitudinal Tracking with Amy Gordon Franzen Rune Labs

Empowered Patient Podcast

Amy Gordon Franzen, CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make more informed treatment decisions. There is also an AI chatbot that allows patients to interrogate their data and receive personalized insights while enabling clinicians and drug developers to...

info_outline
Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI TRANSCRIPT show art Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI TRANSCRIPT

Empowered Patient Podcast

Dr. Sid Kerkar, CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional cell therapy, this technology modifies cells within the body to recognize and eliminate armed mast cells, allowing the body to repopulate with non-reactive cells, preventing severe allergic reactions...

info_outline
Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI show art Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI

Empowered Patient Podcast

Dr. Sid Kerkar, CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional cell therapy, this technology modifies cells within the body to recognize and eliminate armed mast cells, allowing the body to repopulate with non-reactive cells, preventing severe allergic reactions...

info_outline
Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health TRANSCRIPT show art Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health TRANSCRIPT

Empowered Patient Podcast

Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits.  The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain control. Inspired by the hospitalist model, Dimer is defining a transitionist model that is tailored to each patient's needs and home environment, intervening early on minor complications to reduce...

info_outline
Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health show art Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health

Empowered Patient Podcast

Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits.  The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain control. Inspired by the hospitalist model, Dimer is defining a transitionist model that is tailored to each patient's needs and home environment, intervening early on minor complications to reduce...

info_outline
Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran TRANSCRIPT show art Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran TRANSCRIPT

Empowered Patient Podcast

Sharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks.  The organization works with pharmacies to deliver translations created by native-speaking pharmacists rather than by automated systems or untrained interpreters. As this LEP population grows, RxTran advocates for standardized, human-verified translation practices to ensure healthcare access and patient safety across all populations. Sharon explains, "So RxTran’s...

info_outline
Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran show art Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran

Empowered Patient Podcast

Sharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks.  The organization works with pharmacies to deliver translations created by native-speaking pharmacists rather than by automated systems or untrained interpreters. As this LEP population grows, RxTran advocates for standardized, human-verified translation practices to ensure healthcare access and patient safety across all populations. Sharon explains, "So RxTran’s...

info_outline
 
More Episodes

Daniele De Mari, Founder and CEO of Neurogram, points out the significant problem of non-standardized data formats in EEG (electroencephalography), compared to the universal standard used in radiology.  Neurogram has developed a hardware-agnostic, cloud-based solution that standardizes EEG data from various manufacturers, integrates with EMRs, significantly improves clinical workflows, and is accessible from any computer. With improved data security and the ability to analyze large datasets, this platform can support advances in biomarker development for neurological conditions and stimulate more clinical research and collaboration. 

Daniele explains, "So the problem is not 100% on medical exams. It happens exclusively on EEG, and that makes it worse, because it doesn't happen everywhere, it's actually worse for EEG scans. So, knowing a parallel between EEG scans and radiology, every data point in radiology is DICON. So DICON is a universal file format that is standardized. I can send you a DICON over email or to your phone, WhatsApp, and you can open it on your phone. That's how universal it is. That's how open the file type is. It's compatible with EMRs. And so that's awesome. And that's one of the reasons why radiology grows so much. And EEG, it's an electroencephalogram. We have, I would say, 15 different brands around the world. In Brazil, we have seven. In the US, we have top like four or five companies, and they all export data in a different file format. So brand A has its own format, brand B has its own format, brand C, and so forth."

"So we managed to be compatible with most of the brands out there, most of the EEG brands out there. We have a solution that is 100% agnostic and 100% in the cloud, which means we can read from multiple EEG devices out there. If you record in brand A, and I'm not going to say the brands in the podcast, but if you require data from brand A, brand B, brand C, all of it gets standardized into one unified system. So the physician no longer has to log into multiple devices in multiple systems, and it's all in one place. As I said, it's 100% in the cloud, so they can access from a Mac computer, which is now impossible to read EEGs from a Mac computer. Now you can do this. It's compliant. It's HIPAA compliant. We're moving towards the FDA approval process right now for the system, although we're actually selling in Brazil."

#Neurogram #EEG #HealthcareIT #ClinicalNeurophysiology #DigitalHealth #HealthDataStandardization #EMRIntegration #MedicalAI #PatientSafety #HealthcareInnovation

neurogram.com

Download the transcript here

Neurogram